Standard Bariatrics

About Standard Bariatrics

Standard Bariatrics, established in 2014, was a medical device company that emerged from the research and development firm CincyTech. The company was founded by Dr. Jonathan Thompson, a bariatric surgeon, who identified a clinical need for more effective and consistent sleeve gastrectomy procedures. His firsthand experience in the operating room directly informed the design of the company's core product, aiming to address the challenges he faced with existing surgical staplers.

The firm concentrated on the bariatric surgery market, specifically targeting surgeons and hospitals performing sleeve gastrectomies. Its business model revolved around the development and sale of specialized surgical devices. The company's flagship product was the Titan SGS, a long-staple line surgical stapler. This device was designed to enable surgeons to create a more consistent and uniform gastric sleeve anatomy during a single firing, a departure from the multiple firings often required with older technologies. The key benefit of the Titan SGS was its ability to simplify the procedure and potentially reduce surgical time and complications associated with staple line variations.

A significant milestone in the company's trajectory occurred in 2021 when it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Titan SGS. This clearance paved the way for its commercial launch in the United States. Following its successful product introduction and market penetration, Standard Bariatrics was acquired by Teleflex Incorporated, a global provider of medical technologies. The acquisition, valued at an upfront cash payment of $170 million with additional potential payments of up to $130 million based on commercial milestones, integrated Standard Bariatrics into Teleflex's surgical business unit. This strategic move allowed Teleflex to broaden its portfolio in the bariatric surgery space.